Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

• Intra- and interobserver variability in response evaluation metrics used for localized soft tissue sarcoma

  2026 ESMO rare cancers. article Medicine Sarcoma Diagnosis and Treatment Open access

  2

  citations
• Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment

  2025 JAMA Oncology article Medicine Sarcoma Diagnosis and Treatment Open access

  18

  citations
• Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort

  2024 Clinical Pharmacokinetics article Medicine Sarcoma Diagnosis and Treatment Open access

  6

  citations
• Follow-Up after Curative Surgical Treatment of Soft-Tissue Sarcoma for Early Detection of Recurrence: Which Patients Have More or Fewer Visits than Advised in Guidelines?

  2023 Cancers article Medicine Sarcoma Diagnosis and Treatment Open access

  4

  citations
• Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies

  2023 The Oncologist article Medicine Musculoskeletal synovial abnormalities and treatments Open access

  12

  citations
• Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE

  2021 European Journal of Cancer article Medicine IgG4-Related and Inflammatory Diseases Open access

  69

  citations
• Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

  2021 Cancer article Medicine Sarcoma Diagnosis and Treatment Open access cited by 1 patent

  240

  citations
• ASO Author Reflections: Towards Patient-Tailored Management of Extremity Soft Tissue Sarcoma

  2021 Annals of Surgical Oncology article Medicine Sarcoma Diagnosis and Treatment Open access

  0

  citations
• Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas

  2021 Radiotherapy and Oncology article Medicine Sarcoma Diagnosis and Treatment Open access

  4

  citations
• Long‐term outcomes of pexidartinib in tenosynovial giant cell tumors

  2020 Cancer article Medicine Musculoskeletal synovial abnormalities and treatments Open access

  72

  citations
• Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma

  2020 JAMA Oncology article Medicine Sarcoma Diagnosis and Treatment Open access

  107

  citations
• Can we use MRI to detect clinically silent recurrent soft-tissue sarcoma?

  2020 European Radiology article Medicine Sarcoma Diagnosis and Treatment

  30

  citations
• Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

  2020 Cancer article Medicine Sarcoma Diagnosis and Treatment Open access

  148

  citations
• Incidence, treatment and outcome of abdominal metastases in extremity soft tissue sarcoma: Results from a multi‐centre study

  2020 Journal of Surgical Oncology article Medicine Sarcoma Diagnosis and Treatment Open access

  12

  citations

14 results

• Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial

  2020 The Lancet Oncology article Medicine Sarcoma Diagnosis and Treatment Open access

  500

  citations
• Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study

  2020 Journal of Clinical Oncology article Medicine Sarcoma Diagnosis and Treatment

  91

  citations

2 results